Conduit Pharmaceuticals Inc. (NASDAQ: CDT) Stock Information | RedChip

Conduit Pharmaceuticals Inc. (NASDAQ: CDT)


$0.0569
-0.0178 ( +3.46% ) 14.8M

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Market Data


Open


$0.0569

Previous close


$0.0747

Volume


14.8M

Market cap


$6.76M

Day range


$0.0528 - $0.0712

52 week range


$0.0528 - $5.4399

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 20, 2024
4 Insider transactions 1 Nov 20, 2024
4 Insider transactions 1 Nov 20, 2024
4 Insider transactions 1 Nov 20, 2024
4 Insider transactions 1 Nov 20, 2024
8-k 8K-related 16 Nov 19, 2024
8-k 8K-related 14 Nov 14, 2024
10-q/a Quarterly Reports 70 Nov 14, 2024
10-q/a Quarterly Reports 76 Nov 14, 2024
10-q Quarterly Reports 77 Nov 14, 2024

Latest News